Peter Fleming

2.4k total citations · 1 hit paper
50 papers, 1.6k citations indexed

About

Peter Fleming is a scholar working on Epidemiology, Immunology and Surgery. According to data from OpenAlex, Peter Fleming has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Immunology and 7 papers in Surgery. Recurrent topics in Peter Fleming's work include Cytomegalovirus and herpesvirus research (19 papers), Immune Cell Function and Interaction (14 papers) and Herpesvirus Infections and Treatments (8 papers). Peter Fleming is often cited by papers focused on Cytomegalovirus and herpesvirus research (19 papers), Immune Cell Function and Interaction (14 papers) and Herpesvirus Infections and Treatments (8 papers). Peter Fleming collaborates with scholars based in Australia, United Kingdom and United States. Peter Fleming's co-authors include Mariapia A. Degli‐Esposti, Christopher E. Andoniou, Nicholas Davis‐Poynter, Helen E. Farrell, Anthony A. Scalzo, Hiltrud S. Mueller, Donald M. Lynch, Hassan Vally, G. R. Shellam and George P. Noon and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Peter Fleming

46 papers receiving 1.5k citations

Hit Papers

Intra-Aortic Balloon Counterpulsation in Cardiogenic Shock 1973 2026 1990 2008 1973 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Fleming Australia 20 645 576 363 344 321 50 1.6k
Gabor Kandel Canada 25 330 0.5× 247 0.4× 45 0.1× 708 2.1× 118 0.4× 89 1.8k
Mark T. Grattan United States 8 210 0.3× 471 0.8× 322 0.9× 418 1.2× 75 0.2× 10 1.0k
Alfredo Inácio Fiorelli Brazil 18 148 0.2× 788 1.4× 557 1.5× 349 1.0× 118 0.4× 91 1.4k
Robert Beck Germany 20 418 0.6× 988 1.7× 52 0.1× 117 0.3× 102 0.3× 48 1.7k
Nikolaus Neu Austria 23 1.1k 1.7× 427 0.7× 1.3k 3.6× 177 0.5× 32 0.1× 55 2.5k
Vera Demarchi Aiello Brazil 25 185 0.3× 1.4k 2.4× 1.0k 2.8× 658 1.9× 100 0.3× 176 2.4k
Shun‐ichi Kimura Japan 19 86 0.1× 358 0.6× 198 0.5× 193 0.6× 116 0.4× 105 1.2k
Sharon Hunt United States 24 62 0.1× 456 0.8× 566 1.6× 1.4k 4.1× 272 0.8× 49 2.1k
Prakash Balan United States 14 96 0.1× 415 0.7× 456 1.3× 181 0.5× 60 0.2× 41 844
Teresa Español Spain 26 1.6k 2.5× 463 0.8× 77 0.2× 136 0.4× 21 0.1× 67 2.3k

Countries citing papers authored by Peter Fleming

Since Specialization
Citations

This map shows the geographic impact of Peter Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Fleming more than expected).

Fields of papers citing papers by Peter Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Fleming. The network helps show where Peter Fleming may publish in the future.

Co-authorship network of co-authors of Peter Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Fleming. A scholar is included among the top collaborators of Peter Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Fleming. Peter Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Huashan, Peter Fleming, Ying Zhang, et al.. (2025). Reciprocal and non-reciprocal effects of clinically relevant SETBP1 protein dosage changes. Human Molecular Genetics. 34(8). 651–667. 1 indexed citations
2.
Hettige, Nuwan C., Peter Fleming, Xin Zhang, et al.. (2023). FOXG1 targets BMP repressors and cell cycle inhibitors in human neural progenitor cells. Human Molecular Genetics. 32(15). 2511–2522. 3 indexed citations
3.
Schuster, Iona S., Xavier Y.X. Sng, Colleen M. Lau, et al.. (2023). Infection induces tissue-resident memory NK cells that safeguard tissue health. Immunity. 56(3). 531–546.e6. 23 indexed citations
4.
Martins, José Paulo, Christopher E. Andoniou, Peter Fleming, et al.. (2019). Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation. Science. 363(6424). 288–293. 52 indexed citations
5.
Voigt, Valentina, Christopher E. Andoniou, Iona S. Schuster, et al.. (2018). Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye. PLoS Pathogens. 14(5). e1007040–e1007040. 39 indexed citations
6.
Wikström, Matthew E., Peter Fleming, Rachel D. Kuns, et al.. (2015). Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice. Blood. 126(12). 1503–1514. 16 indexed citations
7.
Holmes, Melissa L., Nicholas D. Huntington, Jason Brady, et al.. (2014). Peripheral natural killer cell maturation depends on the transcription factor Aiolos. The EMBO Journal. 33(22). 2721–2734. 57 indexed citations
8.
Andoniou, Christopher E., Vivien R. Sutton, Matthew E. Wikström, et al.. (2014). A Natural Genetic Variant of Granzyme B Confers Lethality to a Common Viral Infection. PLoS Pathogens. 10(12). e1004526–e1004526. 24 indexed citations
9.
Fleming, Peter, Marc Kvansakul, Valentina Voigt, et al.. (2013). MCMV-mediated Inhibition of the Pro-apoptotic Bak Protein Is Required for Optimal In Vivo Replication. PLoS Pathogens. 9(2). e1003192–e1003192. 23 indexed citations
10.
Andrews, Daniel M., Marie J. Estcourt, Christopher E. Andoniou, et al.. (2010). Innate immunity defines the capacity of antiviral T cells to limit persistent infection. The Journal of Experimental Medicine. 207(6). 1333–1343. 173 indexed citations
11.
Zinkernagel, Martin S., Peter Fleming, Holly R. Chinnery, et al.. (2010). In Vivo Imaging of Ocular MCMV Infection. Investigative Ophthalmology & Visual Science. 51(1). 369–369. 7 indexed citations
12.
Manzur, Mitali, Peter Fleming, David C.S. Huang, Mariapia A. Degli‐Esposti, & Christopher E. Andoniou. (2008). Virally mediated inhibition of Bax in leukocytes promotes dissemination of murine cytomegalovirus. Cell Death and Differentiation. 16(2). 312–320. 36 indexed citations
13.
Scalzo, Anthony A., Peter B. Dallas, Catherine A. Forbes, et al.. (2004). The murine cytomegalovirus M73.5 gene, a member of a 3′ co-terminal alternatively spliced gene family, encodes the gp24 virion glycoprotein. Virology. 329(2). 234–250. 8 indexed citations
14.
Fleming, Peter. (1997). A Short History of Cardiology. 32 indexed citations
15.
Fleming, Peter. (1994). The Other Bloomsbury Set: Bayliss, Starling and Thomas Lewis. PubMed. 14(1-2). 91–94. 2 indexed citations
16.
Fleming, Peter, et al.. (1990). Glycosylated hemoglobin in acute myocardial infarction.. PubMed. 30(2). 215–6. 1 indexed citations
17.
Scheidt, Stephen, Gary Wilner, Hiltrud S. Mueller, et al.. (1973). Intra-aortic balloon counterpulsation in cardiogenic shock. Critical Care Medicine. 1(4). 225–225. 1 indexed citations
18.
Handley, A., Peter Emerson, & Peter Fleming. (1972). Heparin in the Prevention of Deep Vein Thrombosis after Myocardial Infarction. BMJ. 2(5811). 436–438. 77 indexed citations
19.
Ayres, Stephen M., Hiltrud S. Mueller, Stanley Giannelli, Peter Fleming, & William J. Grace. (1972). THE LUNG IN SHOCK. Survey of Anesthesiology. 16(2). 98–98. 2 indexed citations
20.
Fleming, Peter. (1963). Auscultation. BMJ. 1(5346). 1667–1667. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026